Antibacterial Activity of Bismuth Oxide Nanoparticles Compared to Amikacin against <i>Acinetobacter baumannii</i> and <i>Staphylococcus aureus</i>

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Isolates</td><td class="align_center">Amikacin (<i>μ</i>g/ml)</td><td class="align_center">Bi<sub>2</sub>O<sub>3</sub> NPs (<i>μ</i>g/ml)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left"><i>S. aureus</i></td><td class="align_center">64</td><td class="align_center">128</td></tr><tr><td class="align_left"><i>A. baumannii</i></td><td class="align_center">16</td><td class="align_center">64</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>MIC of amikacin and Bi<sub>2</sub>O<sub>3</sub> NPs to inhibit <i>S. aureus</i> and <i>A. baumannii</i> isolate biofilm.</div>

Journal of Nanomaterials

tab1

Table 1

Table 1: Antibacterial Activity of Bismuth Oxide Nanoparticles Compared to Amikacin against <i>Acinetobacter baumannii</i> and <i>Staphylococcus aureus</i> 

Journal of Nanomaterials

Antibacterial Activity of Bismuth Oxide Nanoparticles Compared to Amikacin against Acinetobacter baumannii and Staphylococcus aureus

Table 1